Kim Hyung Heon 4
4 · NeuroBo Pharmaceuticals, Inc. · Filed Aug 14, 2023
Insider Transaction Report
Form 4
Kim Hyung Heon
DirectorCEO & President
Transactions
- Award
Common Stock
2023-08-11+625,064→ 625,064 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
- [F2]50% of the RSUs will vest on August 11, 2024, and the remainder will vest in equal monthly installments on the last day of each full month over the subsequent 12 months, subject to continuing service.